The STOP GAP trial comparing prednisolone and ciclosporin for pyoderma gangrenosum is now the subject of an "NIHR Signal".
NIHR Signals are "accessible, timely summaries of the most recent, relevant and important research". They are published every week on the NIHR Discover Portal.
The University of Nottingham King's Meadow Campus Lenton Lane Nottingham, NG7 2NR
telephone: +44 (0) 115 823 1048 email:cebd@nottingham.ac.uk
Browser does not support script.